Evidence map›Paper›PMID 29248255›Full record

ArticleLancet (London, England)2018

Estimates of global seasonal influenza-associated respiratory mortality: a modelling study.

A Danielle Iuliano, Katherine M Roguski, Howard H Chang, David J Muscatello, Rakhee Palekar, Stefano Tempia, Cheryl Cohen, Jon Michael Gran, Dena Schanzer, Benjamin J Cowling and 16 more

Erratum issued 2 registry-linked trialsAbstract read
In one paragraph

Article in Lancet (London, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 2 registered trials, which are not on this map. Cited by 1,790 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1,790citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05521763 naunknown statusnot on this mapstarted 2022, after this paper: background citation

Seasonal Influenza Vaccine Uptake Among Health Care Workers Following Awareness and Availability of Influenza Vaccine Supply in Tertiary Care Hospitals, Bangladesh

TypeinterventionalSponsorInternational Centre for Diarrhoeal Disease Research, BangladeshRan2022 to 2023Enrolled3,000ConditionsInfluenza VaccinesArmsensuring the availability of influenza vaccine supply & developing influenza vaccine awareness
NCT05704335 unknown statusnot on this mapstarted 2022, after this paper: background citation

INFLUENCEF STUDY: Epidemiology, Risk Factors and Clinical Phenotype of Headache Associated With Influenza Infection

TypeobservationalSponsorHospital Clínico Universitario de ValladolidRan2022 to 2024Enrolled100ConditionsHeadache Disorders, Influenza -Like Illness, Head Pain, MigraineArmsQuestionnaire administration
3 · Its place in the literature

Who cites it

1,790 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

1,730 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors.

A Danielle IulianoInfluenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: aiuliano@cdc.gov.
Katherine M RoguskiInfluenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Howard H ChangDepartment of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
David J MuscatelloDepartment of Biostatistics and Bioinformatics, University of New South Wales, Sydney, NSW, Australia.
Rakhee PalekarPan American Health Organization, Washington, DC, USA.
Stefano TempiaInfluenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Cheryl CohenCentre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa.
Jon Michael GranOslo Centre for Biostatistics and Epidemiology, Oslo University Hospital and University of Oslo, Norway; Domain for Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.
Dena SchanzerInfection Disease Prevention and Control Branch, Public Health Agency Canada, Ottawa, ON, Canada.
Benjamin J CowlingWHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.
Peng WuWHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.
Jan KynclDepartment of Infectious Diseases Epidemiology, National Institute of Public Health, Prague, Czech Republic.
Li Wei AngDepartment of Infectious Diseases Epidemiology, Ministry of Health, Singapore.
Minah ParkWHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.
Monika Redlberger-FritzDepartment of Virology, Medical University of Vienna, Vienna, Austria.
Hongjie YuKey Laboratory of Surveillance and Early-warning on Infectious Disease, Division of Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China.
Laura EspenhainDepartment of Infectious Disease Epidemiology, Statens Serum Institut, Copenhagen, Denmark.
Anand KrishnanAll India Institute of Medical Sciences, New Delhi, India.
Gideon EmukuleCenters for Disease Control and Prevention-Kenya, Nairobi, Kenya.
Liselotte van AstenNational Institute for Public Health and the Environment, Bilthoven, Netherlands.
Susana Pereira da SilvaDepartment of Epidemiology, National Health Institute Doutor Ricardo Jorge, Lisbon, Portugal.
Suchunya AungkulanonInternational Health Policy Program, Ministry of Public Health, Nonthaburi, Thailand.
Udo BuchholzDepartment for Infectious Disease Epidemiology, Robert Koch-Institute, Berlin, Germany.
Marc-Alain WiddowsonCenters for Disease Control and Prevention-Kenya, Nairobi, Kenya.
Joseph S BreseeInfluenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Global Seasonal Influenza-associated Mortality Collaborator Network

Funding

Understanding and controlling antibiotic resistanceU54GM088558 · NIGMS · HARVARD SCHOOL OF PUBLIC HEALTH · PI LIPSITCH, MARC · 2009 to 2018
$26.4M
Research on the Epidemiology,Prevention,Vaccine Effectiveness and Treatment of Influenza and Other Respiratory Viruses in South Africa.09U01IP001048 · IP · NATIONAL HEALTH LABORATORY SERVICE · PI COHEN, CHERYL · 2016 to 2020
$19.9M
Intramural CDC HHS CC999999NCIRD CDC HHS U01 IP001048NIGMS NIH HHS U54 GM088558
6 · The paper itself

Abstract

backgroundEstimates of influenza-associated mortality are important for national and international decision making on public health priorities. Previous estimates of 250 000-500 000 annual influenza deaths are outdated. We updated the estimated number of global annual influenza-associated respiratory deaths using country-specific influenza-associated excess respiratory mortality estimates from 1999-2015.

methodsWe estimated country-specific influenza-associated respiratory excess mortality rates (EMR) for 33 countries using time series log-linear regression models with vital death records and influenza surveillance data. To extrapolate estimates to countries without data, we divided countries into three analytic divisions for three age groups (<65 years, 65-74 years, and ≥75 years) using WHO Global Health Estimate (GHE) respiratory infection mortality rates. We calculated mortality rate ratios (MRR) to account for differences in risk of influenza death across countries by comparing GHE respiratory infection mortality rates from countries without EMR estimates with those with estimates. To calculate death estimates for individual countries within each age-specific analytic division, we multiplied randomly selected mean annual EMRs by the country's MRR and population. Global 95% credible interval (CrI) estimates were obtained from the posterior distribution of the sum of country-specific estimates to represent the range of possible influenza-associated deaths in a season or year. We calculated influenza-associated deaths for children younger than 5 years for 92 countries with high rates of mortality due to respiratory infection using the same methods.

findingsEMR-contributing countries represented 57% of the global population. The estimated mean annual influenza-associated respiratory EMR ranged from 0·1 to 6·4 per 100 000 individuals for people younger than 65 years, 2·9 to 44·0 per 100 000 individuals for people aged between 65 and 74 years, and 17·9 to 223·5 per 100 000 for people older than 75 years. We estimated that 291 243-645 832 seasonal influenza-associated respiratory deaths (4·0-8·8 per 100 000 individuals) occur annually. The highest mortality rates were estimated in sub-Saharan Africa (2·8-16·5 per 100 000 individuals), southeast Asia (3·5-9·2 per 100 000 individuals), and among people aged 75 years or older (51·3-99·4 per 100 000 individuals). For 92 countries, we estimated that among children younger than 5 years, 9243-105 690 influenza-associated respiratory deaths occur annually.

interpretationThese global influenza-associated respiratory mortality estimates are higher than previously reported, suggesting that previous estimates might have underestimated disease burden. The contribution of non-respiratory causes of death to global influenza-associated mortality should be investigated.

fundingNone.

Indexed as

SeasonsAdolescentAdultAgedChildChild, PreschoolFemaleGlobal HealthHumansInfantInfant, NewbornInfluenza, HumanLinear ModelsMaleMiddle AgedSocioeconomic Factors

Identifiers

PMID29248255
PMCPMC5935243

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.